Company intelligence / Profile preview
BIOCAD
Saint Petersburg / Strelna district, Leningrad Oblast, Russiaeng.biocad.ru ↗
- Ownership
- Private
- Employees
- ~2600
- Development stage
- Other
01
Overview
BIOCAD has over 60 medical products on the market with more than 40 additional candidates at various stages of development. Its portfolio includes both original biologics and biosimilars for oncology and autoimmune indications. Key assets such as Netakimab are marketed for ankylosing spondylitis and plaque psoriasis. Pembrolizumab biosimilar is in Phase I for solid tumors. The company also develops mRNA vaccines against infectious diseases like COVID-19
- Therapeutic areas
- Infectious DiseasesImmunologyOncology
- Modalities
- Monoclonal antibodies (mAbs)biosimilarssmall moleculesmRNA vaccines
- Industry
- Biotech
02
Drug pipeline
34 assets33 more assets in the full pipeline.
03
Partnerships
Shanghai Pharmaceuticals Holding Co., Ltd. ("SPH") joint venture for clinical trials/manufacturing in China.Collaborations with healthcare facilities approved by Russian Ministry of Health or international regulators.
Beyond the preview
Go deeper on BIOCAD.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOCAD.